As of Feb 03, 2025, Aadi Bioscience, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $92.7. This suggests it may be undervalued by 3,282.7% compared to its current price of around $2.7, using a WACC of 7.7% and growth rates of 3.0%.
As of Feb 03, 2025, Aadi Bioscience, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 7.7%.
As of Feb 03, 2025, Aadi Bioscience, Inc.'s Enterprise Value (EV) is approximately $2,398.8M. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.